990 results on '"French, Neil"'
Search Results
2. CONTRIBUTORS
3. The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi
4. The spatio-temporal distribution of acute encephalitis syndrome and its association with climate and landcover in Vietnam
5. Optimal age targeting for pneumococcal vaccination in older adults; a modelling study
6. Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi
7. Pneumococcal serotypes and risk factors in adult community acquired pneumonia 2018–20: a multicentre UK cohort study
8. The effectiveness of revaccination with pneumococcal polysaccharide vaccine for preventing pneumococcal disease in older adults in England: A population-based cohort study
9. Pregnant women’s attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: Cross-sectional survey
10. Genomic insights into the 2022–2023Vibrio cholerae outbreak in Malawi
11. Trial-of-antibiotics to assist tuberculosis diagnosis in symptomatic adults in Malawi (ACT-TB study): a randomised controlled trial
12. Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data
13. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study
14. Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal conjugate vaccine in Blantyre, Malawi
15. Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine Introduction
16. Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation
17. Social mixing patterns relevant to infectious diseases spread by close contact in urban Blantyre, Malawi
18. Association between household air pollution and nasopharyngeal pneumococcal carriage in Malawian infants (MSCAPE): a nested, prospective, observational study
19. Epidemiology of Human Seasonal Coronaviruses Among People With Mild and Severe Acute Respiratory Illness in Blantyre, Malawi, 2011–2017.
20. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis
21. Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study
22. Inequalities in childhood vaccine uptake: a longitudinal analysis of national coverage in England 2019-23
23. Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Cross-Sectional Study of Women from Bangladesh, Malawi, and the United Kingdom
24. The Effectiveness of Revaccination with Pneumococcal Polysaccharide Vaccine for Preventing Pneumococcal Disease in Older Adults in England: A Population-Based Cohort Study
25. Rapid roll out of SARS-CoV-2 antibody testing—a concern
26. Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies
27. Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination : a time-series and change-point analysis of hospital admissions in England
28. Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings
29. Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection
30. SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
31. Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease
32. Draft genomes of Aeromonas caviae from patients with cholera-like illness during the 2022–2023 cholera outbreak in Malawi
33. Vaccine Effectiveness against DS-1-Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013-2015
34. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
35. Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study
36. Impact of Human Immunodeficiency Virus on the Burden and Severity of Influenza Illness in Malawian Adults : A Prospective Cohort and Parallel Case-Control Study
37. Bacterial genome-wide association study of hyper-virulent pneumococcal serotype 1 identifies genetic variation associated with neurotropism
38. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study
39. 33 - Pneumococcal Disease
40. Cross-sectional health centre and community-based evaluation of the impact of pneumococcal and malaria vaccination on antibiotic prescription and usage, febrile illness and antimicrobial resistance in young children in Malawi: the IVAR study protocol
41. Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: A prospective observational study
42. Respiratory Virus–Associated Severe Acute Respiratory Illness and Viral Clustering in Malawian Children in a Setting With a High Prevalence of HIV Infection, Malaria, and Malnutrition
43. Population genetic structure, antibiotic resistance, capsule switching and evolution of invasive pneumococci before conjugate vaccination in Malawi
44. The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1
45. Pneumococcal disease and its prevention by vaccination in HIV-infected Ugandan adults
46. High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
47. TNFR2+ regulatory T cells protect against bacteremic pneumococcal pneumonia by suppressing IL-17A-producing γδ T cells in the lung
48. The Effectiveness of Pneumococcal Polysaccharide Vaccine Booster-Dosing for Preventing Pneumococcal Disease in Older Adults in England: A Population-Based Cohort Study
49. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses
50. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.